Get access

Commentary on ‘How the debate about comparative effectiveness research (CER) should impact the future of clinical trials’ by Michael S. Lauer


  • Jonas H. Ellenberg

    1. Center for Clinical Epidemiology and Biostatistics, Division of Biostatistics Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.
    Search for more papers by this author

No abstract is available for this article.

Get access to the full text of this article